Home Ingredients Potassium Aspartate
Cardiovascular

Potassium Aspartate

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Potassium aspartate is a potassium salt of the amino acid aspartic acid, providing about 23% elemental potassium by weight. It is marketed for cardiac support, heart rhythm and 'cellular energy,' usually combined with magnesium aspartate, on the premise that aspartate helps shuttle minerals into cells. No human study has compared how well the aspartate salt delivers potassium against cheaper potassium salts, and the NIH Office of Dietary Supplements states that research has not shown any one form of potassium to be better than the others. Outside the US the magnesium-plus-potassium-aspartate combination is sold as an authorised medicine (Panangin, Gedeon Richter) for treating potassium and magnesium deficiency, not as a supplement. The supporting human literature is older, largely European, and centered on mixed potassium-magnesium aspartate combinations rather than potassium aspartate alone. One 3 week randomized trial in 232 patients with frequent ventricular premature beats reported a modest drop in ectopic beat counts on magnesium plus potassium aspartate, but symptoms and repetitive arrhythmias did not change. Four controlled human exercise studies of potassium magnesium aspartate, published between 1982 and 1995, found no effect on endurance time, muscle force, resistance training performance or exercise metabolism. Like all potassium salts, it carries hyperkalemia risk in kidney disease and with potassium-sparing drugs.

Studied Dose 12 mmol potassium (about 470 mg) with 6 mmol magnesium daily in the arrhythmia trial; US supplement servings are about 99 mg.
Active Compound Potassium aspartate (potassium salt of aspartic acid, about 23% elemental potassium by weight); commonly formulated with magnesium aspartate.

Benefits

Provides Potassium in an Amino Acid Salt

Potassium aspartate supplies potassium bound to the amino acid aspartate. It counts toward total potassium intake, but no human study has shown it is absorbed better than potassium chloride, citrate or gluconate, and the NIH Office of Dietary Supplements says research has not found any potassium form superior to the others. At the roughly 99 mg per serving typical of US supplements, it contributes about 3 percent of the 3,400 mg daily adequate intake for adult men.

Supported by Trial 2, Trial 1

Tested in Heart Patients: Fewer Ectopic Beats, No Change in Symptoms

In a 1997 randomized, double-blind, placebo-controlled trial, 232 patients already diagnosed with frequent ventricular premature beats took 6 mmol magnesium plus 12 mmol potassium as dl-hydrogen aspartate for 3 weeks. Median premature beats fell 17.4 percent against 7.4 percent on placebo. The trial found no effect on repetitive or supraventricular arrhythmias and no change in the patients' clinical symptoms, so the thing a person would actually notice did not improve. Magnesium and potassium were given together, so nothing here can be credited to potassium aspartate on its own, and this is not a substitute for prescribed cardiac care.

Supported by Trial 1

Energy Claim: Controlled Trials Found No Effect

Aspartate feeds into cellular energy metabolism, which is where the energy marketing comes from. When the idea was tested it did not hold. In a double-blind study, 8 men given 6 g of potassium magnesium aspartate over 24 hours cycled to exhaustion in 82.7 minutes versus 85.4 minutes on placebo, with no difference in blood glucose, lactate, ammonia or free fatty acids. Three further controlled studies, in trained men walking for 90 minutes, in volunteers holding a static contraction, and in weight trainers, also found nothing. Older reports from the 1960s and 1970s claimed gains of 20 to 50 percent, but the better controlled work did not reproduce them. No trial has measured everyday tiredness or energy on this salt.

Supported by Trial 1, Trial 2

Complements Magnesium

Because potassium and magnesium status are physiologically linked and often depleted together, potassium aspartate is frequently paired with magnesium aspartate to support combined electrolyte adequacy.

Supported by Trial 1, Trial 2

Potassium's Role in Nerve and Muscle Function

Potassium is required for normal muscle contraction and nerve conduction, and any potassium source contributes to that requirement. That is textbook physiology for the mineral rather than a demonstrated effect of this salt: four controlled human studies of potassium magnesium aspartate found no gain in muscle force, endurance time, exercise metabolism or resistance training performance, including a randomized double-blind crossover in 12 weight trainers whose bench press to failure was unchanged. No trial has measured cramps or soreness.

Supported by Trial 1, Trial 2

Mechanism of action

1

Aspartate Mineral Carrier Concept

Aspartate is proposed to act as a carrier that moves potassium and magnesium into cells. This is the marketing rationale for aspartate salts and it has not been demonstrated in people: no published human study compares potassium absorption or intracellular potassium from the aspartate salt against potassium chloride, citrate or gluconate.

2

Electrolyte Stabilization Of Myocardium

Adequate potassium and magnesium help stabilize the resting membrane potential and electrical activity of cardiac cells, the proposed basis for the antiarrhythmic signals seen in some combination trials.

3

Amino Acid Metabolism

Aspartate feeds into the malate-aspartate shuttle and tricarboxylic acid cycle intermediates involved in cellular energy metabolism, supporting the conceptual link between aspartate salts and energy claims.

4

Combined Potassium-Magnesium Effect

Most evidence reflects potassium and magnesium together rather than potassium aspartate alone, making it difficult to attribute any benefit specifically to the potassium aspartate component.

Clinical trials

1
Magnesium plus potassium aspartate in arrhythmia patients: fewer ectopic beats, no symptom change (MAGICA, 1997)
PubMed

Randomized, double-blind, placebo-controlled trial of about 12 mmol potassium and 6 mmol magnesium as dl-hydrogen aspartate daily for 3 weeks (MAGICA)

232 patients with frequent ventricular premature beats

Median ventricular premature beats fell 17.4 percent on the combination against 7.4 percent on placebo. There was no effect on repetitive or supraventricular arrhythmias and no change in the patients' clinical symptoms. Magnesium and potassium were given together, so the result cannot be attributed to potassium aspartate alone, and ectopic beat counts are an ECG measurement rather than an outcome a person feels.

2
Meta-analysis, not a trial of this salt: potassium intake and blood pressure
PubMed

Pooled analysis of 15 randomized trials of potassium supplementation in any salt form and of the sodium-to-potassium ratio. No arm used potassium aspartate. All five authors were employees of Nestle Research Centre, Lausanne

917 pooled participants across 15 separate trials, none taking antihypertensive medication

Potassium supplementation lowered systolic blood pressure by 4.7 mmHg and diastolic by 3.5 mmHg overall, with larger reductions in people with hypertension (6.8 and 4.6 mmHg). This is potassium the nutrient, in whatever salt form the pooled trials used, and it says nothing about the aspartate salt specifically.

Side effects and drug interactions

Common Potential side effects

Mild gastrointestinal upset such as nausea or stomach discomfort can occur.
Excess potassium intake can cause hyperkalemia, which may disturb heart rhythm.
People with kidney impairment are at increased risk of potassium accumulation.
Evidence for antiarrhythmic benefit is modest, so it should not replace prescribed cardiac care.
Symptoms of high potassium include muscle weakness, tingling, and irregular heartbeat.

Important Drug interactions

ACE inhibitors raise serum potassium and combined use increases the risk of hyperkalemia.
Angiotensin receptor blockers (ARBs) similarly elevate potassium and require caution.
Potassium-sparing diuretics like spironolactone can cause dangerous hyperkalemia with added potassium.
People with chronic kidney disease should avoid potassium aspartate unless medically supervised, due to hyperkalemia risk.

More Cardiovascular Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids are polyunsaturated fats. EPA and DHA come from fish, krill and algae…
Cardiovascular
CoEnzyme Q10
Coenzyme Q10 (CoQ10) is a fat-soluble compound the body makes for itself. It carries elect…
Cardiovascular
Beetroot
Beetroot is a vegetable rich in dietary nitrate, which the body converts into nitric oxide…
Cardiovascular
Potassium
Potassium is the main mineral inside the body's cells and an essential nutrient for the el…

Explore Other Ingredients

Muscle & Recovery
L-Glutamine
L-glutamine is the most abundant amino acid in the body and the primary metabolic fuel for…
Muscle & Recovery
Strengthera™
Strengthera™ Muscle Maintenance+Vitality is PLT Health Solutions' botanical blend of Sphae…
Athletic Performance
Senactiv®
Senactiv® (formerly ActiGin®) is a NuLiv Science ingredient made from purified fractions o…

Frequently asked questions about Potassium Aspartate

What is potassium aspartate?

Potassium aspartate is potassium bound to aspartic acid, often combined with magnesium aspartate in products marketed for energy, fatigue and electrolyte support. It is also an authorised medicine outside the US: Panangin, magnesium aspartate plus potassium aspartate, is registered in several European countries for preventing and treating potassium and magnesium deficiency, with contraindications including kidney failure, hyperkalaemia and potassium-sparing diuretics.

What is potassium aspartate used for?

It supplies potassium for electrolyte balance and is often paired with magnesium in energy or anti-fatigue formulas, on the idea that aspartate supports cellular energy. That idea has been tested in four controlled human exercise studies and failed in all of them: no gain in endurance time, no gain in muscle force or resistance training performance, and no change in exercise metabolism. No trial has measured everyday fatigue on this salt.

How much potassium aspartate should I take?

Most US supplements hold to about 99 mg of potassium per serving. That is a labeling convention, not a legal cap on dietary supplements: FDA rules for potassium salt drug products (21 CFR 201.306) attach a prescription caution and a small bowel lesion warning to coated tablets supplying 100 mg or more of potassium each, so supplement servings sit just under that line. A 99 mg serving is roughly 3 percent of the 3,400 mg daily adequate intake for adult men and about one fifth of the 12 mmol used in the arrhythmia trial. Most potassium should come from food; take more only under medical supervision.

Is potassium aspartate safe?

At the small amounts allowed in supplements it is generally well tolerated. People with kidney disease or on potassium-raising medications should avoid supplementing potassium without medical guidance.

What is the recommended dosage of Potassium Aspartate?

The clinically studied dose is 12 mmol potassium (about 470 mg) with 6 mmol magnesium daily in the arrhythmia trial; US supplement servings are about 99 mg. Always follow the product label and check with a healthcare provider for personal advice.

Is Potassium Aspartate safe, and does it have side effects?

For most healthy adults, Potassium Aspartate is well tolerated at studied doses. Reported effects can include: Mild gastrointestinal upset such as nausea or stomach discomfort can occur. Excess potassium intake can cause hyperkalemia, which may disturb heart rhythm. It may also interact with some medications. Potassium Aspartate is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Potassium Aspartate interact with any medications?

Possible interactions include: ACE inhibitors raise serum potassium and combined use increases the risk of hyperkalemia. Angiotensin receptor blockers (ARBs) similarly elevate potassium and require caution. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Potassium Aspartate?

NutraSmarts rates the evidence for Potassium Aspartate as Limited (2 out of 5). It is backed by 2 clinical trials and 5 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(5 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zehender M, Meinertz T, Faber T, Caspary A, Jeron A, Bremm K, Just H Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias Journal of the American College of Cardiology. 1997;J Am Coll Cardiol. 1997 Apr;29(5):1028-34 (MAGICA).PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 232 patients with more than 720 ventricular premature beats per 24 hours. Three weeks of 6 mmol magnesium plus 12 mmol potassium as dl-hydrogen aspartate reduced median premature beats by 17.4 percent against 7.4 percent on placebo. The trial reported no effect on repetitive or supraventricular arrhythmias and no change in the patients' clinical symptoms. Magnesium and potassium were given together, so the effect cannot be assigned to potassium aspartate alone, the participants had a diagnosed cardiac condition rather than being healthy supplement users, and ectopic beat counts are an ECG surrogate.
  2. Binia A, Jaeger J, Hu Y, Singh A, Zimmermann D Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials Journal of Hypertension. 2015;J Hypertens. 2015 Aug;33(8):1509-20.PubMedUsed to support: Meta-analysis of 15 randomized trials (917 pooled participants, none on antihypertensive medication) in which potassium supplementation lowered systolic blood pressure by 4.7 mmHg and diastolic by 3.5 mmHg, with larger reductions in people with hypertension (6.8 and 4.6 mmHg). The pooled trials used potassium as a nutrient in various salt forms and none tested potassium aspartate. All five authors were employees of Nestle Research Centre.
  3. Maughan RJ, Sadler DJ The effects of oral administration of salts of aspartic acid on the metabolic response to prolonged exhausting exercise in man International Journal of Sports Medicine. 1983;Int J Sports Med. 1983 May;4(2):119-23.PubMedUsed to support: Double-blind study in 8 healthy young men given 6 g of potassium-magnesium aspartate over 24 hours or placebo before cycling to exhaustion at about 75 percent of maximum oxygen uptake. Time to exhaustion was 82.7 minutes on aspartate and 85.4 minutes on placebo, with no difference in blood glucose, lactate or ammonia, plasma free fatty acids, or respiratory exchange ratio. The authors concluded there was no beneficial effect of oral aspartate on work capacity in man.
  4. de Haan A, van Doorn JE, Westra HG Effects of potassium + magnesium aspartate on muscle metabolism and force development during short intensive static exercise International Journal of Sports Medicine. 1985;Int J Sports Med. 1985 Feb;6(1):44-9.PubMedUsed to support: Combined rat and human study of oral potassium plus magnesium aspartate. In human volunteers neither the exerted force nor the endurance time of a submaximal static contraction increased after dosing. In electrically stimulated rat quadriceps, ATP, phosphocreatine, lactate and L-aspartate were unchanged and force was not enhanced. The 20 to 50 percent improvements in muscle performance reported in the earlier literature were not reproduced. The published abstract does not state how many volunteers took part or whether the human arm was blinded, and most of the paper is in rats.
  5. Franzoni F, Mataloni E, Femia R, Galetta F Effect of oral potassium supplementation on QT dispersion in anorexia nervosa Acta Paediatrica. 2002;Acta Paediatr. 2002;91(6):653-6.PubMedUsed to support: The closest thing to a study of potassium aspartate on its own. 28 young women with anorexia nervosa were allocated (not randomized, with no placebo) into two groups of 14; the group given oral potassium aspartate at 60 mEq per day for 4 weeks ended with higher serum potassium (4.21 versus 3.91 mmol/L) and lower QT dispersion (44.2 versus 63.2 ms) than the untreated group. The participants were potassium-depleted patients rather than healthy people, the dose is roughly 24 times a US supplement serving, and QT dispersion is an ECG measurement, not a symptom or a cardiac event.